Charenton le Pont, France

Jerome Concialdi

This inventor holds 1 USPTO granted patent. Top assignee: Essilor International (Compagnie Generale D'optique). Active years: 2017.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jerome Concialdi: Innovator in Ophthalmic Lens Processing

Introduction

Jerome Concialdi is a notable inventor based in Charenton le Pont, France. He has made significant contributions to the field of ophthalmic lens manufacturing. His innovative approach has led to the development of a unique method for processing order requests for ophthalmic lenses.

Latest Patents

Jerome Concialdi holds 1 patent for his invention titled "Method of processing an order request for an ophthalmic lens." This patent outlines a systematic approach to processing order requests, which includes receiving prescription information, applying predetermined processing rules, and managing manufacturing parameters. The method ensures that the ophthalmic lenses are manufactured accurately according to the wearer's specifications.

Career Highlights

Jerome is currently employed at Essilor International, a leading company in the optical industry. His work focuses on enhancing the efficiency and accuracy of ophthalmic lens production. His expertise in processing order requests has positioned him as a valuable asset to the company.

Collaborations

Jerome collaborates with his coworker, Laurent Marcepoil, to further innovate in the field of ophthalmic lens manufacturing. Their combined efforts aim to improve the overall quality and efficiency of lens production processes.

Conclusion

Jerome Concialdi's contributions to ophthalmic lens processing exemplify the importance of innovation in the optical industry. His patented method not only streamlines the manufacturing process but also enhances the accuracy of lens production. His work at Essilor International continues to impact the field positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…